Mia's Feed
Medical News & Research

AI Innovation Enables Detection of Fatty Liver Disease via Chest X-Rays

AI Innovation Enables Detection of Fatty Liver Disease via Chest X-Rays

Share this article

Innovative AI model analyzes routine chest X-rays to detect fatty liver disease, offering a cost-effective and accessible diagnostic method that could transform early screening strategies.

2 min read

Recent advancements in artificial intelligence (AI) have paved the way for new, more accessible methods to diagnose fatty liver disease, a condition affecting approximately one in four individuals globally. Traditionally, identifying fatty liver requires specialized imaging tests such as ultrasounds, CT scans, or MRIs, which can be costly and less readily available. However, researchers from Osaka Metropolitan University have developed an innovative AI model that leverages routine chest X-ray images to detect this condition.

While chest X-rays are primarily used to evaluate the lungs and heart, they also inadvertently capture parts of the liver. This serendipitous overlap allows for deep learning models to analyze these images for signs of fatty liver disease. A study involving 6,599 X-ray images from 4,414 patients utilized controlled attenuation parameter (CAP) scores to train the AI. The model demonstrated high accuracy, with an area under the receiver operating characteristic curve (AUC) between 0.82 and 0.83, indicating strong diagnostic potential.

The integration of AI with commonly performed and affordable chest X-rays could significantly improve early detection of fatty liver disease. Professor Sawako Uchida-Kobayashi highlighted the potential impact, stating that developing such diagnostic methods using readily available imaging could enhance screening efforts and facilitate timely treatment.

This breakthrough was detailed in the journal Radiology: Cardiothoracic Imaging and represents a promising step toward more efficient and cost-effective liver disease diagnostics. As research progresses, this approach could become a routine part of medical assessments, enabling broader screening and better patient outcomes.

Source: https://medicalxpress.com/news/2025-06-ai-fatty-liver-disease-chest.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Breakthrough Research Offers Hope for Innovative Treatments for Spinal Muscular Atrophy and Autism

New research highlights the role of mitochondria in neurological disorders like SMA and autism, opening pathways for innovative and safer treatments. Discover how cellular energy regulators influence brain development and neuron degeneration.

Breakthrough Phase III Trial Confirms Canagliflozin's Safety and Effectiveness for Treating Type 2 Diabetes in Youths

A groundbreaking Phase III trial confirms that canagliflozin is safe and effective for managing type 2 diabetes in children and adolescents, offering new hope for treatment options in this vulnerable group.

New Insights on Early Measles Vaccination to Prevent Global Outbreaks

Emerging research suggests that administering the measles vaccine earlier than current guidelines could significantly strengthen immunity in infants and help control global outbreaks of the highly contagious disease.